Ophthalmology · Abilene, TX
NPI
1669407227
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2959 Buffalo Gap Rd
Abilene, TX, 79605
Phone (325) 701-9885
Groups this clinician bills Medicare through
Medicare paid, 2024
$272K
4,084 services
Medicare patients, 2024
856
Average age 76
Drug cost, 2024
$775K
5,556 prescriptions
Company payments, 2025
$666
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anca D Pacuraru was code 92250 (angiography), 677 times for 675 patients. In total Anca D Pacuraru billed 4,084 services in 39 codes, and Medicare paid $272K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92250 Angiography | Office | 677 | 675 | $25.89 | $18K |
| 99213 Office E&M - Established | Office | 661 | 490 | $63.17 | $42K |
| 92014 Ophthalmological E&M | Office | 651 | 651 | $84.67 | $55K |
| 92133 Computerized Ophthalmic Imaging | Office | 466 | 390 | $24.80 | $12K |
| 99212 Office E&M - Established | Office | 398 | 258 | $41.04 | $16K |
| 92083 Vision, Hearing, and Speech Services | Office | 361 | 335 | $44.96 | $16K |
| 92020 Ophthalmological E&M | Office | 212 | 207 | $19.42 | $4,118 |
| 92134 Computerized Ophthalmic Imaging | Office | 139 | 110 | $30.57 | $4,249 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 122 | 78 | $179.19 | $22K |
| 92004 Ophthalmological E&M | Office | 114 | 114 | $88.12 | $10K |
| 66984 Cataract Surgery | Facility | 67 | 39 | $398.73 | $27K |
| 92136 Ultrasound - Nonspecific | Office | 48 | 48 | $35.09 | $1,684 |
| 76514 Ultrasound - Nonspecific | Office | 45 | 45 | $7.54 | $339 |
| 66821 Cataract Surgery | Office | 20 | 19 | $260.08 | $5,202 |
| 66991 Cataract Surgery | Facility | 14 | 11 | $549.58 | $7,694 |
By year: 2022 $266K for 4,039 services; 2023 $265K for 4,038 services; 2024 $272K for 4,084 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anca D Pacuraru prescribed most often to Medicare patients was Latanoprost, with 827 prescriptions and refills. In total Anca D Pacuraru wrote 5,556 Medicare prescriptions that cost $775K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 827 | 1,147 | 170 | $5,936 |
| Levobunolol Hcl Generic | 443 | 614 | 79 | $8,761 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 439 | 845 | 114 | $6,907 |
| Timolol Maleate Generic | 432 | 738 | 110 | $13K |
| Brimonidine Tartrate Generic | 334 | 503 | 85 | $25K |
| Ketorolac Tromethamine Generic | 295 | 394 | 160 | $5,382 |
| Lumigan Bimatoprost | 278 | 345 | 50 | $81K |
| Prednisolone Acetate Generic | 252 | 335 | 164 | $9,823 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 205 | 264 | 37 | $22K |
| Travoprost Generic | 198 | 263 | 41 | $18K |
| Restasis Cyclosporine | 174 | 244 | 64 | $139K |
| Xiidra Lifitegrast | 172 | 226 | 51 | $149K |
| Ciprofloxacin Hcl Generic | 169 | 174 | 120 | $1,814 |
| Erythromycin Erythromycin Base | 125 | 127 | 95 | $1,392 |
| Combigan Brimonidine Tartrate/Timolol | 116 | 164 | 25 | $33K |
Brand drugs: - claims; generic drugs: 3,321 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anca D Pacuraru $666 ($666 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $359.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $359 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $119 |
| Alcon Vision LLC ALC | 3 | $85.3 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $72.28 |
| Dompe US, Inc. | 1 | $31.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.